About
Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.
Key Metrics
as of Sep 2026Market Cap13 Cr
P/E20.10
Div Yield0.00 %
Book Value₹19.50
52w High₹27.60
52w Low₹15.90
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.57 | 5.47 | 3.85 | 5.16 | 4.83 | 5.22 | 5.40 | 5.64 | 6.29 | 3.21 | 7.66 | 8.09 | 8.18 |
| Expenses | 6.92 | 4.13 | 4.05 | 4.43 | 4.28 | 4.72 | 4.81 | 5.08 | 5.30 | 3.19 | 6.87 | 7.37 | 7.05 |
| Operating Profit | 0.65 | 1.34 | -0.20 | 0.73 | 0.55 | 0.50 | 0.59 | 0.56 | 0.99 | 0.02 | 0.79 | 0.72 | 1.13 |
| OPM % | 8.59 | 24.50 | -5.19 | 14.15 | 11.39 | 9.58 | 10.93 | 9.93 | 15.74 | 0.62 | 10.31 | 8.90 | 13.81 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.32 | 0.40 | 0.32 | 0.39 | 0.38 | 0.32 | 0.31 | 0.33 | 0.28 | 0.32 | 0.31 | 0.29 | 0.28 |
| Interest | 0.06 | 0.07 | 0.09 | 0.08 | 0.10 | 0.08 | 0.12 | 0.12 | 0.21 | 0.13 | 0.11 | 0.10 | 0.12 |
| Profit before tax | 0.27 | 0.87 | -0.61 | 0.26 | 0.07 | 0.10 | 0.16 | 0.11 | 0.50 | -0.43 | 0.37 | 0.33 | 0.73 |
| Tax % | 18.52 | 34.48 | -72.13 | 96.15 | 71.43 | -50.00 | 62.50 | 90.91 | 26.00 | -16.28 | 16.22 | 18.18 | 27.40 |
| Net Profit | 0.22 | 0.56 | -0.17 | 0.01 | 0.02 | 0.15 | 0.05 | 0.01 | 0.37 | -0.35 | 0.31 | 0.27 | 0.53 |
| EPS in Rs | 0.43 | 1.10 | -0.34 | 0.02 | 0.04 | 0.30 | 0.10 | 0.02 | 0.73 | -0.69 | 0.61 | 0.53 | 1.05 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.31 | 21.15 | 26.73 | 26.84 | 14.48 | 14.03 | 12.78 | 12.81 | 15.08 | 10.90 | 12.99 | 13.23 |
| Expenses | 16.89 | 19.91 | 24.45 | 24.84 | 14.04 | 12.58 | 11.87 | 11.78 | 14.04 | 10.96 | 12.49 | 12.50 |
| Operating Profit | 2.42 | 1.24 | 2.28 | 2.00 | 0.44 | 1.45 | 0.91 | 1.03 | 1.04 | -0.06 | 0.50 | 0.73 |
| OPM % | 12.53 | 5.86 | 8.53 | 7.45 | 3.04 | 10.33 | 7.12 | 8.04 | 6.90 | -0.55 | 3.85 | 5.52 |
| Other Income | 0.00 | 1.41 | 0.40 | 0.27 | 0.16 | 0.64 | 0.23 | 0.24 | 0.69 | 0.27 | 0.37 | 0.18 |
| Interest | 0.34 | 0.54 | 0.47 | 0.47 | 0.46 | 0.47 | 0.32 | 0.15 | 0.13 | 0.20 | 0.21 | 0.26 |
| Depreciation | 1.49 | 1.25 | 1.20 | 0.81 | 1.09 | 1.27 | 0.66 | 0.32 | 0.33 | 0.38 | 0.41 | 0.52 |
| Profit before tax | 0.59 | 0.86 | 1.01 | 0.99 | -0.95 | 0.35 | 0.16 | 0.80 | 1.27 | -0.37 | 0.25 | 0.13 |
| Tax % | 27.12 | 33.72 | 23.76 | 22.22 | -30.53 | 31.43 | 68.75 | 26.25 | 22.05 | 18.92 | 32.00 | 38.46 |
| Net Profit | 0.42 | 0.58 | 0.77 | 0.77 | -0.66 | 0.24 | 0.05 | 0.59 | 0.99 | -0.45 | 0.17 | 0.08 |
| EPS in Rs | 0.83 | 1.14 | 1.52 | 1.52 | -1.30 | 0.47 | 0.10 | 1.16 | 1.95 | -0.89 | 0.34 | 0.16 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 |
| Reserves | 4.79 | 4.41 | 3.83 | 2.97 | 2.20 | 2.84 | 2.53 | 2.43 | 1.57 | 0.79 | 1.57 | 1.40 |
| Borrowings | 2.44 | 4.07 | 5.09 | 4.54 | 5.29 | 5.12 | 5.23 | 3.25 | 1.48 | 1.72 | 1.69 | 1.72 |
| Other Liabilities | 2.64 | 2.39 | 3.48 | 4.92 | 5.25 | 5.60 | 4.07 | 3.80 | 2.69 | 2.85 | 1.80 | 2.71 |
| Total Liabilities | 14.96 | 15.96 | 17.49 | 17.52 | 17.83 | 18.65 | 16.92 | 14.57 | 10.83 | 10.45 | 10.15 | 10.92 |
| Fixed Assets | 7.04 | 6.20 | 6.17 | 6.03 | 6.04 | 7.52 | 8.60 | 1.96 | 2.22 | 2.25 | 2.44 | 2.43 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.24 | 0.08 | 0.00 | 0.00 | 0.24 |
| Investments | 0.00 | 0.00 | 0.00 | 0.15 | 0.16 | 0.12 | 0.56 | 0.48 | 0.22 | 0.49 | 0.68 | 0.68 |
| Other Assets | 7.92 | 9.76 | 11.32 | 11.34 | 11.63 | 11.01 | 7.76 | 5.89 | 8.31 | 7.71 | 7.03 | 7.57 |
| Total Assets | 14.96 | 15.96 | 17.49 | 17.52 | 17.83 | 18.65 | 16.92 | 14.57 | 10.83 | 10.45 | 10.15 | 10.92 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 3.65 | 2.64 | 0.82 | 2.48 | -0.29 | 0.34 | 0.18 | 3.35 | -0.10 | 0.37 | -0.13 | 0.70 |
| Cash from Investing Activity | -2.16 | -0.40 | -1.08 | -1.30 | 0.54 | 0.26 | -1.55 | -5.01 | -0.03 | 0.32 | 0.17 | 0.02 |
| Cash from Financing Activity | -2.03 | -1.55 | 0.10 | -1.17 | -0.43 | -0.54 | 1.67 | 1.62 | -0.36 | -0.19 | -0.23 | -0.09 |
| Net Cash Flow | -0.54 | 0.69 | -0.16 | 0.01 | -0.18 | 0.06 | 0.30 | -0.04 | -0.49 | 0.50 | -0.19 | 0.63 |
| Free Cash Flow | -0.17 | 1.35 | -0.51 | 1.73 | 0.10 | 0.10 | -1.70 | -2.87 | -0.01 | 0.19 | -0.33 | 0.47 |
| CFO/OP % | 157.00 | 227.00 | 45.00 | 127.00 | -43.00 | 25.00 | 36.00 | 350.00 | 1.00 | -833.00 | 6.00 | 125.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39.51 | 94.23 | 103.51 | 93.83 | 112.17 | 118.11 | 98.53 | 98.02 | 116.91 | 102.47 | 100.59 | 102.08 |
| Inventory Days | 116.93 | — | — | 245.67 | — | 1,135.00 | 486.67 | 39.74 | 53.10 | 151.29 | 65.28 | 64.34 |
| Days Payable | 53.42 | — | — | 758.08 | — | 1,110.00 | 755.17 | 93.60 | 57.03 | 65.24 | 34.34 | 69.91 |
| Cash Conversion Cycle | 103.02 | 94.23 | 103.51 | -418.57 | 112.17 | 143.11 | -169.97 | 44.16 | 112.97 | 188.52 | 131.54 | 96.50 |
| Working Capital Days | 39.32 | 68.00 | 57.90 | 46.51 | 47.14 | 38.76 | 13.99 | -6.55 | 71.89 | 67.31 | 58.44 | 38.35 |
| ROCE % | 7.18 | 10.15 | 11.05 | 11.60 | -3.82 | 2.86 | 4.06 | 9.94 | 11.94 | -2.26 | 5.56 | 5.20 |
Corporate Actions
No corporate actions recorded.